Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adults with Major Depressive Disorder (MDD) (SAVITRI)Official TitleStudy to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adults with Major Depressive Disorder (MDD) (SAVITRI)Purpose
The purpose of this study is to evaluate the effectiveness and safety of NBI-1065845 compared with placebo. In addition to the study drug, participants will continue their normal antidepressant medications. The main goal of this study is to examine the improving symptoms of depression.
The duration of the study will last 14 weeks, including up to 4 weeks of screening, 8 weeks of study drug dosing, and a follow-up period of 2 weeks.Could this study be right for you?
• Aged 18-65 years old
• Have a diagnosis of Major Depressive Disorder (MDD)
• Currently depressed
• Poor response to antidepressant treatmentAge Range18 and up
Studying a New Method to Evaluate Blood Flow in Patients with Peripheral Artery Disease (PAD)Official TitleRadiotracer Imaging of Lower Extremity Skeletal Muscle Perfusion in Patients with Peripheral Arterial DiseasePurpose
The purpose of this study is to study a new method to evaluate blood flow to the calves and feet. We hope this information can help evaluate the effectiveness of treatments and predict clinical outcomes. Participants will be required to attend one (2 hr) session at Nationwide Children's Hospital.Could this study be right for you?
-Diagnosis of Peripheral Arterial Disease (PAD) OR leg symptoms, such as muscle pain or cramping AND/OR foot wound that has required medical consultation Healthy volunteers - must be at least 40 years of age - no history of cardiovascular disease (including high blood pressure) - no history of diabetes mellitus - non-smoker - normal BMIAge Range40 and up
Studying the Effect of Using Virtual Reality with Spinal Cord Stimulation to Manage PainOfficial TitleInvestigating mechanisms underlying spinal cord stimulation efficacy using virtual reality and full body illusionPurpose
This study is being to see if using virtual reality (VR) along with spinal cord stimulation can help better manage pain. Research has shown that using this type of “leg illumination” virtual reality reduces pain. We hope to further this research by identifying which sensory pathway (part of the nervous system that makes one aware of what one feels) causes pain to decrease. If the Virtual Realty acts through a different sensory pathway than a spinal cord stimulator, those with pain may have some additional pain relief.
This study will require 2 study visits; one will last approximately 1 hour, and the other visit will last about 5 hours throughout the day.Could this study be right for you?
1. Age 18–and older at the time of enrollment
2. Individuals who are experiencing lower extremity pain e.g. neuropathy, Complex Regional Pain Syndromes (CRPS) type-1, neuropathic leg pain following Failed Back Surgery (FBS) etc.
3. Those who have an implanted epidural Spinal Cord Stimulator (SCS)
4. The SCS implantation for at least three months prior to enrollmentAge Range18 and up
Studying the Effects Nitrous Oxide (Laughing Gas) Has on AggressionOfficial TitleNitrous Oxide and Cortico-Limbic Function in Aggression (Laughing Gas Study or LGS).Purpose
The purpose of this study is to see how laughing gas (nitrous oxide) changes brain activity in study participants with and without “anger issues”. Brain activity is measured by Magnetic Resonance Imaging.
The length of time you will be involved in this study will be 4-8 weeks.Could this study be right for you?
- You are a medically healthy man or woman
- You are between the ages of 21 and 55 years of age
- Do not abuse alcohol or other drugs
- With a current history of “anger issues”
- Able to complete study sessions during the weekAge Range21 and up
The ARCADIA Study -- A medication study for prevention of recurrent ischemic strokeOfficial TitleAtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke (ARCADIA)Purpose
The purpose of this research study is to compare the effects (good and bad) of apixaban with the effects (good and bad) of aspirin in patients with unexplained strokes and atrial cardiopathy to see which is better at prevention of future strokes.Could this study be right for you?
- You are at least 45 years old
- Clinical diagnosis of ischemic stroke* of unknown cause (ESUS or cryptogenic) in the last 120 days
- Underwent an echocardiogram as part of your stroke work up
- No history of atrial fibrillation (irregular heartbeat)
- No known allergy or intolerance to aspirin or apixaban
*An “ischemic” stroke is an injury to the brain caused by a blocked blood vessel supplying the brain.Age Range45 and up
The Brain Exercise StudyOfficial TitleStrategies for the Development of Social Cognitive Training for Impulsive Aggression (Brain Exercise Study or BES).Purpose
The purpose of this study is to see if brain exercise done on the computer can reduce aggression in those with “anger issues”. The study is a six-week clinical trial using selected brain exercises versus other computer-based exercises.Could this study be right for you?
- Medically healthy man or woman - You are between 21 and 55 years of age - With a current history of “anger issues” - You have regular access to a computer and a smart phoneAge Range21 and up
The EASE StudyOfficial TitleA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE MATERNA PREP DEVICE IN REDUCING PELVIC MUSCLE INJURIES DURING VAGINAL DELIVERYPurpose
This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery.Could this study be right for you?
You may be eligible for this study if you:
1. Are scheduled for vaginal birth.
2. Are pregnant with a single fetus.
3. Haven't given birth previously, or had a previous pregnancy terminated within 24 weeks gestation.
4. Are willing to comply with the protocol required follow-up visits.
5. Are able and willing to provide written informed consent prior to enrollment.
6. Are 18 years of age or older at time of consent.
You will be ineligible for this study if you:
1. Have a high likelihood of less than 1 hour of potential device dilation time after you arrive at the hospital.
2. Have a need for or is planning a Caesarean-section.
3. Begin labor with less than 36 weeks gestation.
4. Have a neurological disorder that could cause pelvic floor dysfunction, such as multiple sclerosis or spinal cord injury
5. Have a collagen-associated disorder that affects tissue elasticity, such as scleroderma or Ehlers-Danlos syndrome
6. Have a localized (genital tract) or systemic infection.
7. Have had prior surgical procedures to the vaginal anatomy which could lead to pelvic floor dysfunction, such as pelvic fractures or pelvic soft tissue injuries
8. Have any general health condition or systemic disease that may represent, in the opinion of the investigator, a potential increased risk associated with device use or pregnancy.
9. Have placenta previa or vasa previa.
10. Have a known significant chromosomal or structural fetal anomalies.
11. Have a category 2 and/or 3 fetal tracing that is unresolved.Age Range18 and up
The Emerging Adulthood Health ProjectOfficial TitleThe Emerging Adulthood Health ProjectPurpose
Researchers at The Ohio State University are looking for teens and young adults to participate in an online research study aimed at better understanding people’s health behaviors and attitudes. Participation involves a 10-15 minute baseline survey and three 5-10 minute follow-up surveys. Links to these surveys would be emailed to you.Could this study be right for you?
- You are a teen or young adult - Have access to smart device or computer with internet to be able to complete surveys
The Family Risk StudyOfficial TitleParental History of Suicidal Behavior and Early Markers of Risk in Pre-pubescent YouthPurpose
The purpose of this study is to learn what factors may be related to suicide attempt(s) in children (ages 6 - 9) that have a parental history of suicidal behavior in hopes that this information will help prevent and treat self-harm behavior in youth at high risk.
Both parents and children will complete questionnaires, interview questions, and a family discussion in addition to problem solving tasks and computer games.
There are multiple study visits. The first will last about 2.5 to 3 hours and all other appointments will occur annually from your first appointment. Due to COVID-19, families will have the option to conduct annual follow-up appointments via telephone. These annual telephone visits will last approximately 30-45 minutes. If the annual visit is conducted in-person, it will last 1.5 to 2.5 hours.Could this study be right for you?
- Parents and children must be able to read and understand English fluently
- Child is 6 to 9 years of age
- Meet other criteria (e.g., no traumatic brain injury) for the studyAge Range6 and up
The impact of E-Cigarette use on the lungsOfficial TitleThe Effects of a Standardized Research E-Cigarette on the Human LungPurpose
This study will look at the effects of electronic cigarette (e-cig) use on the lung (particularly lung inflammation). The study will be of 160 smokers. Some participants will be given a standardized research e-cig (SREC) or nicotine replacement therapy (NRT). The information from this study will help researchers learn if there is any short-term harm to the lung when using e-cigs.
*Samples for the study will taken by two bronchoscopy procedures.Could this study be right for you?
You may be eligible if you:
- Are 21- 40 years old
- Are a smokerAge Range21 and up
The Ohio State Lupus, Vasculitis and Glomerulonephritis RegistryOfficial TitleThe Ohio State Lupus, Vasculitis and Glomerulonephritis RegistryPurpose
The purpose of the OSU Lupus and Vasculitis Registry is to obtain clinical and laboratory information about lupus and vasculitis and glomerulonephritis.Could this study be right for you?
Patients at the Ohio State University Rheumatology and Lupus Clinic with one of the following diagnoses who are ages 18 years of age and older:
- Systemic lupus erythematosus
- Discoid lupus
- Mixed connective tissue disorder
- Undifferentiated connective tissue disorder
- Wegener’s granulomatosus
- Microscopic polyangiitis
- Henoch-Schonlien Purpura
- Takayasu’s arteritis
- Giant cell/temporal arteritis
- Churg-Strauss vasculitis
- Other vasculitides
- IgA nephropathy
- Anti-GBM GN
- Membranous GN
- Minimal Change Disease
- Focal Segmental GlomerulosclerosisAge Range18 and up
The REGENERATE Study - A study to evaluate the effectiveness and safety of a medication (Obeticholic Acid) for those with NASH (nonalcoholic steatohepatitis)Official TitleA Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic SteatohepatitisPurpose
This research study is for those who have nonalcoholic steatohepatitis (NASH) (meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue). Because of your condition, you may be eligible for a research study on an investigational drug for your condition. The Regenerate Study will assess the safety and effectiveness of the investigational medication obeticholic acid (OCA) compared to placebo in delaying specific medical conditions or health related issues that can occur in patients with nonalcoholic steatohepatitis (NASH) (meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue).Could this study be right for you?
- Age 18 or older
- Diagnosed with Stage 2 or 3 NASH (nonalcoholic steatohepatitis--meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue).
If you are eligible and decide to take part in this research study, you will need to complete 1 or 2 screening visits to see if you are eligible to participate in the study. Once the study doctor determines you can participate in the study, you will be asked to come back to the clinic 8 times (for the Month 0 [Day 1] Visit, the Month 1 Visit, the Month 3 Visit, and then every 3 months) for the first 18 months you are in the study and then 2 times per year (every 6 months) for each additional year you are in the study.Age Range18 and up